| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| rp173717-500μg |
500μg |
期货  |
| |
| rp173717-1mg |
1mg |
期货 |
|
| 产品名称 | complement C3 |
|---|---|
| 规格或纯度 | Moligand™ |
| CAS编号和信息 | rp173717 |
|---|
| 1. Zhang Y, Shao D, Ricklin D, Hilkin BM, Nester CM, Lambris JD, Smith RJ. (2015) Compstatin analog Cp40 inhibits complement dysregulation in vitro in C3 glomerulopathy.. Immunobiology, 220 (8): (993-8). [PMID:25982307] |
| 2. Kajikawa T, Briones RA, Resuello RRG, Tuplano JV, Reis ES, Hajishengallis E, Garcia CAG, Yancopoulou D, Lambris JD, Hajishengallis G. (2017) Safety and Efficacy of the Complement Inhibitor AMY-101 in a Natural Model of Periodontitis in Non-human Primates.. Mol Ther Methods Clin Dev, 6 (207-215). [PMID:28879212] |
| 3. Mastaglio S, Ruggeri A, Risitano AM, Angelillo P, Yancopoulou D, Mastellos DC, Huber-Lang M, Piemontese S, Assanelli A, Garlanda C et al.. (2020) The first case of COVID-19 treated with the complement C3 inhibitor AMY-101.. Clin Immunol, 215 (108450). [PMID:32360516] |
首页
400-620-6333
